107 related articles for article (PubMed ID: 8860280)
21. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
Buki LP; Jamison J; Anderson CJ; Cuadra AM
Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
[TBL] [Abstract][Full Text] [Related]
23. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research.
Bowman JA; Redman S; Dickinson JA; Gibberd R; Sanson-Fisher RW
Health Serv Res; 1991 Apr; 26(1):97-107. PubMed ID: 2016170
[TBL] [Abstract][Full Text] [Related]
24. English proficiency and physicians' recommendation of Pap smears among Hispanics.
De Alba I; Sweningson JM
Cancer Detect Prev; 2006; 30(3):292-6. PubMed ID: 16844320
[TBL] [Abstract][Full Text] [Related]
25. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
Couzos S; Wronski I; Murray R; Cox H
Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
[TBL] [Abstract][Full Text] [Related]
26. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
28. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
Koval AE; Riganti AA; Foley KL
N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
[TBL] [Abstract][Full Text] [Related]
29. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
[TBL] [Abstract][Full Text] [Related]
30. Screening for cervical cancer: will women accept less?
Sirovich BE; Woloshin S; Schwartz LM
Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
[TBL] [Abstract][Full Text] [Related]
31. Determinants and evolution of squamous intraepithelial lesions in HIV-infected women, 1991-2004.
Drogoul-Vey MP; Marimoutou C; Robaglia-Schlupp A; Beerli M; Gastaut JA; Cau P; Poizot-Martin I
AIDS Care; 2007 Sep; 19(8):1052-7. PubMed ID: 17852004
[TBL] [Abstract][Full Text] [Related]
32. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
33. Uptake of Pap smears among women in a large Israeli HMO between 2006 and 2008.
Raz R; Shavit O; Stein M; Cohen R; Schejter E; Chodick G; Shalev V
Public Health; 2012 Jul; 126(7):594-9. PubMed ID: 22657092
[TBL] [Abstract][Full Text] [Related]
34. Self-reports of Pap smear screening in women with physical disabilities.
Lin JD; Chen SF; Lin LP; Sung CL
Res Dev Disabil; 2011; 32(2):456-61. PubMed ID: 21273042
[TBL] [Abstract][Full Text] [Related]
35. The use of Pap smear and its influencing factors among women with disabilities in Taiwan.
Huang KH; Tsai WC; Kung PT
Res Dev Disabil; 2012; 33(2):307-14. PubMed ID: 22100350
[TBL] [Abstract][Full Text] [Related]
36. Cervical screening in general practice: call and recall.
Ridsdale LL
J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
[TBL] [Abstract][Full Text] [Related]
37. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
38. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic cytological investigation for cervical cancer in relation to stage at diagnosis: a study of 420 women in Denmark.
Olesen F
J R Coll Gen Pract; 1988 Aug; 38(313):356-9. PubMed ID: 3256647
[TBL] [Abstract][Full Text] [Related]
40. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
Makino H; Sato S; Yajima A; Fukao A
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
